4//SEC Filing
Moran Michael Shawn 4
Accession 0001209191-22-015024
CIK 0000827871other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 6:11 PM ET
Size
5.2 KB
Accession
0001209191-22-015024
Insider Transaction Report
Form 4
Moran Michael Shawn
EVP, Chief Commercial Officer
Transactions
- Award
Common Stock
2022-02-28+10,400→ 32,115 total
Footnotes (1)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting of the unit. The shares issuable in respect of such RSUs shall vest with respect to 25% of the shares of common stock on each of the one, two, three and four-year anniversaries of February 28, 2022, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
Documents
Issuer
EAGLE PHARMACEUTICALS, INC.
CIK 0000827871
Entity typeother
Related Parties
1- filerCIK 0001886788
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 6:11 PM ET
- Size
- 5.2 KB